US SB516 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 14 2019 - 25% progression, died in committee
Action: 2019-02-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 14 2019 - 25% progression, died in committee
Action: 2019-02-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Expands the notification and reporting requirements with respect to potentially addictive prescription drugs for states receiving funds for a Prescription Drug Monitoring Program (PDMP). Dispensers of these drugs, which includes substances listed in schedule II, III, or IV of the Controlled Substances Act, must consult with the PDMP before starting treatment involving such drugs and report each prescription of such drugs to the PDMP within 24 hours.The state agency administering a PDMP must analyze reported data for patterns of controlled substance misuse or abuse and provide certain information to law enforcement, the public, and other states.
Title
Prescription Drug Monitoring Act of 2019
Sponsors
Sen. Amy Klobuchar [D-MN] | Sen. Rob Portman [R-OH] | Sen. Angus King [I-ME] | Sen. Joe Manchin [D-WV] |
History
Date | Chamber | Action |
---|---|---|
2019-02-14 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB3974 (Same As) 2019-07-26 - Referred to the Subcommittee on Health.
Subjects
Criminal justice information and records
Drug trafficking and controlled substances
Health
Health information and medical records
Health personnel
Intergovernmental relations
Licensing and registrations
Medical ethics
Prescription drugs
State and local government operations
Drug trafficking and controlled substances
Health
Health information and medical records
Health personnel
Intergovernmental relations
Licensing and registrations
Medical ethics
Prescription drugs
State and local government operations
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/516/all-info |
Text | https://www.congress.gov/116/bills/s516/BILLS-116s516is.pdf |